Risk factors for venous thrombosis - Current understanding from an epidemiological point of view

British Journal of Haematology

Volumn 149, Issue 6, 2010, Pages 824-833

  Lijfering, Willem M ^a,b   Rosendaal, Frits R ^a   Cannegieter, Suzanne C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Aetiology; Epidemiology; Risk factors; Thrombophilia; Venous thrombosis

Indexed keywords

COMPARATIVE STUDY; DISEASE MARKER; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; GENETIC PREDISPOSITION; HUMAN; MATHEMATICAL MODEL; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; VEIN THROMBOSIS;

CAUSALITY; HUMANS; MODELS, BIOLOGICAL; RECURRENCE; RISK FACTORS; VENOUS THROMBOSIS;

EID: 77952737014     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08206.x     Document Type: Review

References (95)

1. Ageno, W., Becattini, C., Brighton, T., Selby, R. Kamphuisen, P.W. (2008) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation, 117, 93 102.
2. van Aken, B.E., Reitsma, P.H. Rosendaal, F.R. (2002) Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. British Journal of Haematology, 116, 173 177.
3. Andreou, E.R., Koru-Sengul, T., Linkins, L., Bates, S.M., Ginsberg, J.S. Kearon, C. (2008) Differences in clinical presentation of deep vein thrombosis in men and women. Journal of Thrombosis and Haemostasis, 6, 1713 1719.
4. Annual Review of Civil Aviation 2006) International Civil Aviation Organization Journal, 61, 1 44.
5. Baccarelli, A., Martinelli, I., Pegoraro, V., Melly, S., Grillo, P., Zanobetti, A., Hou, L., Bertazzi, P.A., Mannucci, P.M. Schwartz, J. (2009) Living near major traffic roads and risk of deep vein thrombosis. Circulation, 119, 3118 3124.
6. Baglin, T., Luddington, R., Brown, K. Baglin, C. (2003) Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet, 362, 523 526.
7. Bank, I., van de Poel, M.H., Coppens, M., Hamulyák, K., Prins, M.H., van der Meer, J., Veeger, N.J., Büller, H.R. Middeldorp, S. (2007) Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study. Thrombosis and Haemostasis, 98, 1040 1044.
8. Bates, S.M., Greer, I.A., Pabinger, I., Sofaer, S. Hirsh, J. (2008) Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133 (Suppl. 6 844S 886S. (Pubitemid 351892978)
9. Bezemer, I.D., Bare, L.A., Doggen, C.J., Arellano, A.R., Tong, C., Rowland, C.M., Catanese, J., Young, B.A., Reitsma, P.H., Devlin, J.J. Rosendaal, F.R. (2008) Gene variants associated with deep vein thrombosis. Journal of the American Medical Association, 299, 1306 1314.
10. Blom, J.W., Doggen, C.J., Osanto, S. Rosendaal, F.R. (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. Journal of the American Medical Association, 293, 715 722. (Pubitemid 40216041)
11. Brouwer, J.L., Bijl, M., Veeger, N.J., Kluin-Nelemans, H.C. van der Meer, J. (2004) The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood, 104, 143 148.
12. Brouwer, J.L., Veeger, N.J., Kluin-Nelemans, H.C. van der Meer, J. (2006) The pathogenesis of venous thromboembolism: evidence for multiple interrelated causes. Annals of Internal Medicine, 145, 807 815.
13. Brummel-Ziedins, K.E., Vossen, C.Y., Butenas, S., Mann, K.G. Rosendaal, F.R. (2005) Thrombin generation profiles in deep venous thrombosis. Journal of Thrombosis and Haemostasis, 3, 2497 2505.
14. Cannegieter, S.C., Doggen, C.J., van Houwelingen, H.C. Rosendaal, F.R. (2006) Travel-related venous thrombosis: results from a large population-based case control study (MEGA study). PLoS Medicine, 3, e307.
15. Chandra, D., Parisini, E. Mozaffarian, D. (2009) Meta-analysis: travel and risk for venous thromboembolism. Annals of Internal Medicine, 151, 180 190.
16. Christiansen, S.C., Cannegieter, S.C., Koster, T., Vandenbroucke, J.P. Rosendaal, F.R. (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. Journal of the American Medical Association, 293, 2352 2361.
17. Christiansen, S.C., Naess, I.A., Cannegieter, S.C., Hammerstrøm, J., Rosendaal, F.R. Reitsma, P.H. (2006) Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study. PLoS Medicine, 3, e334.
18. Cogo, A., Lensing, A.W., Prandoni, P. Hirsh, J. (1993) Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound. Archives of Internal Medicine, 153, 2777 2780.
19. Cushman, M., Glynn, R.J., Goldhaber, S.Z., Moll, S., Bauer, K.A., Deitcher, S., Shrivastava, S. Ridker, P.M. (2006) Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial. Journal of Thrombosis and Haemostasis, 4, 2199 2203.
20. De Stefano, V., Martinelli, I., Rossi, E., Battaglioli, T., Za, T., Mannuccio Mannucci, P. Leone, G. (2006) The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. British Journal of Haematology, 135, 386 391.
21. Deslandes, M. (1759) Traité des Accouchements de M. Puzos. Desaint & Saillant
22. Doggen, C.J., Berckmans, R.J., Sturk, A., Manger Cats, V. Rosendaal, F.R. (2000) C-reactive protein, cardiovascular risk factors and the association with myocardial infarction in men. Journal of Internal Medicine, 248, 406 414.
23. Eischer, L., Eichinger, S. Kyrle, P.A. (2009) Age at first venous thromboembolism and risk of recurrence: a prospective cohort study. Medicine (Baltimore), 88, 366 370.
24. Faioni, E.M., Valsecchi, C., Palla, A., Taioli, E., Razzari, C. Mannucci, P.M. (1997) Free protein S deficiency is a risk factor for venous thrombosis. Thrombosis and Haemostasis, 78, 1343 1346.
25. Franco, R.F., Reitsma, P.H., Lourenço, D., Maffei, F.H., Morelli, V., Tavella, M.H., Araújo, A.G., Piccinato, C.E. Zago, M.A. (1999) Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis. Thrombosis and Haemostasis, 81, 676 679.
26. Geerts, W.H., Bergqvist, D., Pineo, G.F., Heit, J.A., Samama, C.M., Lassen, M.R. Colwell, C.W. American College of Chest Physicians 2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133 (Suppl. 6 381S 453S.
27. Ginsberg, J.S., Wells, P.S., Brill-Edwards, P., Donovan, D., Moffatt, K., Johnston, M., Stevens, P. Hirsh, J. (1995) Antiphospholipid antibodies and venous thromboembolism. Blood, 86, 3685 3691.
28. Glynn, R.J. Rosner, B. (2005) Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. American Journal of Epidemiology, 162, 975 982.
29. Grainge, M.J., West, J. Card, T.R. (2010) Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet, 375, 657 663.
30. Greenland, S., Pearl, J. Robins, J.M. (1999) Causal diagrams for epidemiologic research. Epidemiology, 10, 37 48.
31. Grodstein, F., Stampfer, M.J., Goldhaber, S.Z., Manson, J.E., Colditz, G.A., Speizer, F.E., Willett, W.C. Hennekens, C.H. (1996) Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet, 348, 983 987.
32. Hansson, P.O., Sörbo, J. Eriksson, H. (2000) Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Archives of Internal Medicine, 160, 769 774.
33. Heijboer, H., Brandjes, D.P., Büller, H.R., Sturk, A. ten Cate, J.W. (1990) Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. New England Journal of Medicine, 323, 1512 1516.
34. den Heijer, M., Koster, T., Blom, H.J., Bos, G.M., Briet, E., Reitsma, P.H., Vandenbroucke, J.P. Rosendaal, F.R. (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. New England Journal of Medicine, 334, 759 762. (Pubitemid 26089357)
35. Heit, J.A., Silverstein, M.D., Mohr, D.N., Petterson, T.M., Lohse, C.M., O'Fallon, W.M. Melton, 3rd., L.J. (2001) The epidemiology of venous thromboembolism in the community. Thrombosis and Haemostasis, 86, 452 463.
36. Heit, J.A., Leibson, C.L., Ashrani, A.A., Petterson, T.M., Bailey, K.R. Melton, 3rd., L.J. (2009) Is diabetes mellitus an independent risk factor for venous thromboembolism?: A population-based case-control study. Arteriosclerosis Thrombosis and Vascular Biology, 29, 1399 1405.
37. van Hylckama Vlieg, A. Rosendaal, F.R. (2003) Interaction between oral contraceptive use and coagulation factor levels in deep venous thrombosis. Journal of Thrombosis and Haemostasis, 1, 2186 2190.
38. van Hylckama Vlieg, A., van der Linden, I.K., Bertina, R.M. Rosendaal, F.R. (2000) High levels of factor IX increase the risk of venous thrombosis. Blood, 95, 3678 3682.
39. Jick, H., Slone, D., Westerholm, B., Inman, W.H., Vessey, M.P., Shapiro, S., Lewis, G.P. Worcester, J. (1969) Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet, 1, 539 542.
40. Kakkar, V.V., Howe, C.T., Nicolaides, A.N., Renney, J.T. Clarke, M.B. (1970) Deep vein thrombosis of the leg. Is there a "high risk" group?. American Journal of Surgery, 120, 527 530.
41. Kierkegaard, A. (1983) Incidence and diagnosis of deep vein thrombosis associated with pregnancy. Acta Obstetricia et Gynecologica Scandinavica, 62, 239 243.
42. Koster, T., Rosendaal, F.R., de Ronde, H., Briët, E., Vandenbroucke, J.P. Bertina, R.M. (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet, 342, 1503 1506.
43. Koster, T., Rosendaal, F.R., Reitsma, P.H., van der Velden, P.A., Briët, E. Vandenbroucke, J.P. (1994) Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms - the Leiden Thrombophilia Study (LETS). Thrombosis and Haemostasis, 71, 719 722.
44. Koster, T., Blann, A.D., Briët, E., Vandenbroucke, J.P. Rosendaal, F.R. (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet, 345, 152 155.
45. Kuipers, S., Cannegieter, S.C., Middeldorp, S., Robyn, L., Büller, H.R. Rosendaal, F.R. (2007a) The absolute risk of venous thrombosis after air travel: a cohort study of 8 755 employees of international organisations. PLoS Medicine, 4, e290.
46. Kuipers, S., Schreijer, A.J., Cannegieter, S.C., Büller, H.R., Rosendaal, F.R. Middeldorp, S. (2007b) Travel and venous thrombosis: a systematic review. Journal of Internal Medicine, 262, 615 634.
47. Kuipers, S., Cannegieter, S.C., Doggen, C.J. Rosendaal, F.R. (2009) Effect of elevated levels of coagulation factors on the risk of venous thrombosis in long-distance travelers. Blood, 113, 2064 2069.
48. Kyrle, P.A., Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Schneider, B., Weltermann, A., Speiser, W., Lechner, K. Eichinger, S. (2000) High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. New England Journal of Medicine, 343, 457 462. (Pubitemid 30646484)
49. Kyrle, P.A., Minar, E., Bialonczyk, C., Hirschl, M., Weltermann, A. Eichinger, S. (2004) The risk of recurrent venous thromboembolism in men and women. New England Journal of Medicine, 350, 2558 2563.
50. Lapostolle, F., Surget, V., Borron, S.W., Desmaizières, M., Sordelet, D., Lapandry, C., Cupa, M. Adnet, F. (2001) Severe pulmonary embolism associated with air travel. New England Journal of Medicine, 345, 779 783.
51. Lawlor, D.A., Harbord, R.M., Timpson, N.J., Lowe, G.D., Rumley, A., Gaunt, T.R., Baker, I., Yarnell, J.W., Kivimäki, M., Kumari, M., Norman, P.E., Jamrozik, K., Hankey, G.J., Almeida, O.P., Flicker, L., Warrington, N., Marmot, M.G., Ben-Shlomo, Y., Palmer, L.J., Day, I.N., Ebrahim, S. Smith, G.D. (2008) The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4 610 cases amongst 18 637 participants. PLoS ONE, 3, e3011.
52. Lijfering, W.M. van der Meer, J. (2009) Pharmacological prevention of venous thromboembolism. In : Deep Vein Thrombosis and Pulmonary Embolism (ed. by E.J. van Beek, H.R. Büller M. Oudkerk 2nd edn, pp. 435 461. John Wiley and Sons
53. Lijfering, W.M., Brouwer, J.L., Veeger, N.J., Bank, I., Coppens, M., Middeldorp, S., Hamulyák, K., Prins, M.H., Büller, H.R. van der Meer, J. (2009a) Selective testing for thrombophilia in patients with first venous thrombosis: Results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood, 113, 5314 5322.
54. Lijfering, W.M., Veeger, N.J., Middeldorp, S., Hamulyák, K., Prins, M.H., Büller, H.R. van der Meer, J. (2009b) A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families. Blood, 114, 2031 2036.
55. Lisman, T., de Groot, P.G., Meijers, J.C. Rosendaal, F.R. (2005) Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood, 105, 1102 1105.
56. Mahmoodi, B.K., Brouwer, J.L., Veeger, N.J. van der Meer, J. (2008a) Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: Results from a large family cohort study. Circulation, 118, 1659 1667.
57. Mahmoodi, B.K., ten Kate, M.K., Waanders, F., Veeger, N.J., Brouwer, J.L., Vogt, L., Navis, G. van der Meer, J. (2008b) High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation, 117, 224 230.
58. Mahmoodi, B.K., Gansevoort, R.T., Veeger, N.J., Matthews, A.G., Navis, G., Hillege, H.L. van der Meer, J., Prevention of Renal and Vascular End-stage Disease (PREVEND) Study Group 2009) Microalbuminuria and risk of venous thromboembolism. Journal of the American Medical Association, 301, 1790 1797.
59. Malone, C.P. Agutter, P.S. (2008) The Aetiology of Deep Venous Thrombosis: A Critical, Historical and Epistemiological Survey, 1st edn. Springer Science + Business Media B.V.
60. Mannucci, P.M. (2002) Venous thrombosis: the history of knowledge. Pathophysiology of Haemostasis and Thrombosis, 32, 209 212.
61. McColl, M.D., Ramsay, J.E., Tait, R.C., Walker, I.D., McCall, F., Conkie, J.A., Carty, M.J. Greer, I.A. (1997) Risk factors for pregnancy associated venous thromboembolism. Thrombosis and Haemostasis, 78, 1183 1188.
62. McRae, S., Tran, H., Schulman, S., Ginsberg, J. Kearon, C. (2006) Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet, 368, 371 378.
63. Meijers, J.C., Tekelenburg, W.L., Bouma, B.N., Bertina, R.M. Rosendaal, F.R. (2000) High levels of coagulation factor XI as a risk factor for venous thrombosis. New England Journal of Medicine, 342, 696 701.
64. Middeldorp, S. van Hylckama Vlieg, A. (2008) Does thrombophilia testing help in the clinical management of patients? British Journal of Haematology, 143, 321 335.
65. Morabia, A. (2004). Epidemiology: an epistemological perspective. In : History of Epidemiological Methods and Concepts (ed. by A. Morabia pp. 1 126. Birkhauser
66. Naess, I.A., Christiansen, S.C., Romundstad, P., Cannegieter, S.C., Rosendaal, F.R. Hammerstrøm, J. (2007) Incidence and mortality of venous thrombosis: a population-based study. Journal of Thrombosis and Haemostasis, 5, 692 699.
67. Nicolaides, A., Irving, D., Pretzell, M., Dupont, P., Lewis, J., Desai, S., Douglas, J.N., Kakkar, V.V. Field, E.S. (1973) The risk of deep-vein thrombosis in surgical patients. British Journal of Surgery, 60, 312.
68. Pengo, V. Prandoni, P. (2006) Sex and anticoagulation in patients with idiopathic venous thromboembolism [letter]. Lancet, 368, 342 343.
69. Poli, D., Zanazzi, M., Antonucci, E., Bertoni, E., Salvadori, M., Abbate, R. Prisco, D. (2006) Renal transplant recipients are at high risk for both symptomatic and asymptomatic deep vein thrombosis. Journal of Thrombosis and Haemostasis, 4, 988 992.
70. Pomp, E.R., le Cessie, S., Rosendaal, F.R. Doggen, C.J. (2007) Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. British Journal of Haematology, 139, 289 296.
71. Pomp, E.R., Rosendaal, F.R. Doggen, C.J. (2008) Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. American Journal of Hematology, 83, 97 102.
72. Poort, S.R., Rosendaal, F.R., Reitsma, P.H. Bertina, R.M. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 3698 3703.
73. Prandoni, P., Noventa, F., Ghirarduzzi, A., Pengo, V., Bernardi, E., Pesavento, R., Iotti, M., Tormene, D., Simioni, P. Pagnan, A. (2007) The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1 626 patients. Haematologica, 92, 199 205.
74. Quist-Paulsen, P., Naess, I.A., Cannegieter, S.C., Romundstad, P.R., Christiansen, S.C., Rosendaal, F.R. Hammerstrøm, J. (2010) Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2). Haematologica, 95, 119 125.
75. Rosendaal, F.R. (1999) Venous thrombosis: a multicausal disease. Lancet, 353, 1167 1173.
76. Rosendaal, F.R. (2006) Interventions to prevent venous thrombosis after air travel: are they necessary? No. Journal of Thrombosis and Haemostasis, 4, 2306 2307.
77. Rosendaal, F.R. (2009) Causes of Venous Thrombosis. In : Deep Vein Thrombosis and Pulmonary Embolism (ed. by E.J. van Beek, H.R. Büller M. Oudkerk 2nd ed. pp. 1 26. John Wiley and Sons
78. Rosendaal, F.R., Koster, T., Vandenbroucke, J.P. Reitsma, P.H. (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood, 85, 1504 1508.
79. Rothman, K.J. (2002). Types of Epidemiologic study. In : Epidmiology: An Introduction (ed. by K.J. Rothman 1st ed, pp. 57 93. Oxford University Press Inc.
80. Roumen-Klappe, E.M., Janssen, M.C., Van Rossum, J., Holewijn, S., Van Bokhoven, M.M., Kaasjager, K., Wollersheim, H. Den Heijer, M. (2009) Inflammation in deep vein thrombosis and the development of post-thrombotic syndrome: a prospective study. Journal of Thrombosis and Haemostasis, 7, 582 587.
81. Sackett, D.L. (1979) Bias in analytic research. Journal of Chronic Diseases, 32, 51 63.
82. Sartwell, P.E., Masi, A.T., Arthes, F.G., Greene, G.R. Smith, H.E. (1969) Thromboembolism and oral contraceptives: an epidemiologic case-control study. American Journal of Epidemiology, 90, 365 380.
83. Sarvesvaran, R. (1986) Sudden natural deaths associated with commercial air travel. Medicine, Science, and the Law, 26, 35 38.
84. Simioni, P., Sanson, B.J., Prandoni, P., Tormene, D., Friederich, P.W., Girolami, B., Gavasso, S., Huisman, M.V., Büller, H.R., Wouter ten Cate, J., Girolami, A. Prins, M.H. (1999) Incidence of venous thromboembolism in families with inherited thrombophilia. Thrombosis and Haemostasis, 81, 198 202.
85. Smeeth, L., Cook, C., Thomas, S., Hall, A.J., Hubbard, R. Vallance, P. (2006) Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet, 367, 1075 1079.
86. Smith, N.L., Hindorff, L.A., Heckbert, S.R., Lemaitre, R.N., Marciante, K.D., Rice, K., Lumley, T., Bis, J.C., Wiggins, K.L., Rosendaal, F.R. Psaty, B.M. (2007) Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. Journal of the American Medical Association, 297, 489 498.
87. Sullivan, P.S., Dworkin, M.S., Jones, J.L. Hooper, W.C. (2000) Epidemiology of thrombosis in HIV-infected individuals. The Adult/Adolescent Spectrum of HIV Disease Project. AIDS, 14, 321 324.
88. van Tilburg, N.H., Rosendaal, F.R. Bertina, R.M. (2000) Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis. Blood, 95, 2855 2859.
89. Tsai, A.W., Cushman, M., Rosamond, W.D., Heckbert, S.R., Polak, J.F. Folsom, A.R. (2002) Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Archives of Internal Medicine, 162, 1182 1189. (Pubitemid 34522408)
90. Virchow, R. (1856) Phlogose und Trombose im Gefäßystem Fesammelte Abhandelungen zur Wissenschaftlichen Medizin. Staatsdruckerei
91. van Vlijmen, E.F., Brouwer, J.L., Veeger, N.J., Eskes, T.K., de Graeff, P.A. van der Meer, J. (2007) Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study. Archives of Internal Medicine, 167, 282 289.
92. Vossen, C.Y., Conard, J., Fontcuberta, J., Makris, M., van der Meer, F.J., Pabinger, I., Palareti, G., Preston, F.E., Scharrer, I., Souto, J.C., Svensson, P., Walker, I.D. Rosendaal, F.R. (2005) Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). Journal of Thrombosis and Haemostasis, 3, 459 464.
93. Wattanakit, K., Cushman, M., Stehman-Breen, C., Heckbert, S.R. Folsom, A.R. (2008) Chronic kidney disease increases risk for venous thromboembolism. Journal of the American Society of Nephrology, 19, 135 140.
94. van Zaane, B., Squizzato, A., Huijgen, R., van Zanten, A.P., Fliers, E., Cannegieter, S.C., Büller, H.R., Gerdes, V.E. Brandjes, D.P. (2010) Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study. Blood, doi:.
95. Zhu, T., Martinez, I. Emmerich, J. (2009) Venous thromboembolism: risk factors for recurrence. Arteriosclerosis Thrombosis and Vascular Biology, 29, 298 310.